Laurie Smith

Cancer statistics, 2022

Cancer statistics, 2023

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP

Head and neck squamous cell carcinoma

Cancer statistics, 2024

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Cancer Statistics, 2021

Cost-effectiveness studies of HPV self-sampling: A systematic review

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

Human Papillomavirus-Associated Cancers

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Pyroptosis: mechanisms and diseases

Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?

Metaprop: a Stata command to perform meta-analysis of binomial data

Cervical cancer

Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies

Sexually Transmitted Infections Treatment Guidelines, 2021

Optimizing secondary prevention of cervical cancer: Recent advances and future challenges

Screening for Cervical Cancer in Primary Care

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

Synergistically enhanced colorimetric molecular detection using smart cup: a case for instrument-free HPV-associated cancer screening

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions

Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation

Screening for Cervical Cancer

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

Implementation Considerations Using HPV Self-Collection to Reach Women Under-Screened for Cervical Cancer in High-Income Settings

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial

Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program

Exploring Colposcopists' Attitudes Towards Use of HPV Testing as a Primary Screening Tool for Cervical Cancer in British Columbia

Impacts of Human Papillomavirus Immunization Programs on Rates of Anogenital Warts in British Columbia, Canada, 2000 to 2017

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV‐based primary screening to liquid‐based cytology for cervical cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

Eurogin roadmap 2017: Triage strategies for the management of HPV‐positive women in cervical screening programs

Women's intentions to receive cervical cancer screening with primary human papillomavirus testing

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months

Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program